Feilan Chen
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ocular Diseases and Behçet’s Syndrome 9
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Zhaohua Tang (6 shared papers)Zili Liu (5 shared papers)Yan Chen (1 shared paper)Jie Gao (1 shared paper)Yongguo Li (1 shared paper)Shengping Hou (6 shared papers)Peizeng Yang (4 shared papers)Zhengxuan Jiang (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Journal of Neuro-Oncology (2 papers)Veterinary Ophthalmology (1 paper)Biochimie (1 paper)Biomedicines (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Feilan Chen
23 papers receiving 432 citations
Peers
Comparison fields: 5 of 78
- Ophthalmology 81
- Cancer Research 98
- Biological Psychiatry 7
- Genetics 29
- Rheumatology 39
Countries citing papers authored by Feilan Chen
This map shows the geographic impact of Feilan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilan Chen more than expected).
Fields of papers citing papers by Feilan Chen
This network shows the impact of papers produced by Feilan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilan Chen. The network helps show where Feilan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Feilan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 176 | |
| 2 | 2021 | 41 | |
| 3 | 2012 | 38 | |
| 4 | 2011 | 33 | |
| 5 | 2008 | 24 | |
| 6 | 2022 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 19 | |
| 9 | Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population. | 2010 | 13 |
| 10 | 2016 | 10 | |
| 11 | 2010 | 9 | |
| 12 | 2016 | 7 | |
| 13 | 2022 | 4 | |
| 14 | CD40 polymorphisms in Han Chinese patients with Fuch uveitis syndrome. | 2011 | 4 |
| 15 | PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. | 2019 | 3 |
| 16 | 2020 | 3 | |
| 17 | [Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats]. | 2020 | 3 |
| 18 | 2020 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2016 | 1 |
About Feilan Chen
Feilan Chen is a scholar working on Ophthalmology, Molecular Biology, Cancer Research, Oncology and Epidemiology, having authored 25 papers that have together received 436 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (9 papers), Cytomegalovirus and herpesvirus research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Erythropoietin and Anemia Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Biomedical Research and Pathophysiology (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Ophthalmology (81 citations), Cancer Research (98 citations), Biological Psychiatry (7 citations), Genetics (29 citations) and Rheumatology (39 citations). Feilan Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhaohua Tang, Zili Liu, Yan Chen, Jie Gao, Yongguo Li, Shengping Hou, Peizeng Yang, Zhengxuan Jiang, Fuzhen Li and Qinmeng Shu. Their work appears in journals such as Frontiers in Immunology, Journal of Neuro-Oncology, Veterinary Ophthalmology, Biochimie and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.